Net Income

With fresh funding, Primmune is advancing its unique TLR7 agonist, designed for efficacy without severe side effects, into a pivotal melanoma trial in Australia.

PIMCO Canada launches a new 'one-ticket' balanced fund, blending passive global stocks and active bonds to revive the 60/40 strategy for modern investors.

VanEck's new VAVX offers investors the first regulated US vehicle for AVAX exposure, complete with staking rewards, signaling a new era for altcoins.

A worker's death at Serabi Gold's Coringa mine puts the company's ambitious growth plans and safety record under intense scrutiny in Brazil.

A hefty Q4 loss driven by a renewable diesel reversal and plant issues overshadows full-year profit, signaling a major strategic shift for 2026.

Onity Group is raising $150 million via high-yield notes, a strategic but risky move to refinance debt and fund growth amid a complex financial backdrop.

A new external bioengineered liver has passed a crucial safety trial, offering a potential lifeline for patients with acute liver failure.

Janux Therapeutics appoints Dr. William Go, a key leader behind YESCARTA®'s approval, as CMO to steer its novel immunotherapy pipeline through critical trials.

Papa John's declared a $0.46 quarterly dividend, signaling stability to investors while it pursues major cost-cutting and refranchising initiatives.

The Puerto Rico-based bank boosts its quarterly payout, rewarding investors amid a complex market, but analysts suggest its strengths may already be priced in.

As consolidation reshapes healthcare, Integrated Dermatology's new CMO appointment signals a strategic move to blend clinical leadership with corporate growth.

Leidos will acquire ENTRUST Solutions Group in a landmark deal, creating a $1.3B energy engineering powerhouse to tackle North America's aging power grid.

Digital-first Wio Bank partners with fintech giant Pine Labs, deploying a modern platform to fast-track merchant payments and fuel the UAE's digital economy.

JCPenney offers a free lab-grown diamond necklace for old jewelry, a bold move tapping into the 'breakup economy' and the booming lab-diamond market.

Singapore's Basel Medical has 180 days to reverse its sub-$1 stock price or face delisting, a crisis compounded by prior financial reporting issues.

Medical device maker Nuwellis appoints two new directors and sees three resign, a move tied directly to a critical upcoming $5 million equity investment.

Facing a Nasdaq delisting threat, K Wave Media bets on a risky mix of K-content IP and a massive Bitcoin treasury to save its $50M valuation.

Eaton's acquisition of Ultra PCS signals a major push into next-gen aerospace, integrating critical control and sensing tech for future aircraft.

LuminArx and SkyWorks have launched SkyLight, a $1 billion lending platform offering secured debt to a capital-hungry global aviation market.

AEKE's new K1 smart gym combines an AI personal trainer with a disruptive one-time purchase model, aiming to shake up the subscription-heavy fitness market.